With China, we have in place a longstanding official mechanism, the Joint Commission on Commerce and Trade (JCCT). Through the JCCT, China has made commitments to streamline drug and medical device approvals, apply its antitrust rules in a nondiscriminatory way, suspend IT measures in the banking sector that previously discriminated against foreign products, strengthen its law protecting trade secrets, and ensure non-discriminatory treatment of foreign firms as it creates policies to develop its semiconductor industry. We are intently focused on implementing these and other commitments.
Source: https://www.huffpost.com/entry/increasing-opportunities_b_10718196